Marcelo DaSilva, MD, FACS
I am glad to share with you some of my professional and leadership experiences as a practicing tripled Board-Certified Surgeon and Diplomat of the American Board of Surgery.
I completed my residency in general surgery and surgical critical care training at Penn State University, Hershey Medical Center (PSU-HMC) in 1999. My training in cardiothoracic (heart and lung transplantation) was done at Loyola University Medical Center from 2002-2004. In 2007, I received a scholarship to attend the Leadership in Health Policy-Management at Heller School for Social Policy Management, Brandeis University. This scholarship was granted by the Society of Thoracic Surgery and the American College of Surgeons. In that same year, I was the national recipient of The Mark Young International Medical Studies Scholarship to participate in the International Forum of Health Care in Barcelona, Spain. In the summer of 2008, I joined the division of thoracic surgery at the Brigham and Women’s Hospital, as an instructor in surgery at Harvard Medical School. While at the Brigham, I was an active member of the International Mesothelioma Program (IMP). Founded in 2002, the IMP has grown to become a leading national program in the treatment of patients with malignant mesothelioma. The IMP provided me with a solid platform to learn how an integrated, focused, and multidisciplinary approach to a line of treatment could be effective in delivering excellence to our patients. In the winter of 2013, I was invited to lead the section of thoracic surgery at Loyola University Medical Center in Chicago. I joined Loyola as Co-Director of the Lung Cancer Program at the Cardinal Bernardin Cancer Center, Chief of Thoracic Surgery and Associate Professor of Surgery at Stritch School of Medicine. In 2015, I rejoined the Brigham and Women’s Hospital (BWH). My role as a thoracic surgeon is two-fold, to assist with the Benign Chest Wall Disease Program and to develop a Thoracic Surgery Program at Care New England (CNE) in Rhode Island. Simultaneously, we organized the first Course on Innovations in Chest Wall Surgery at Harvard Medical School. Our chest wall program focused on the treatment of adult pectus excavatum, 3D reconstruction of chest wall problems, innovation, and technology. In 2016, we spearheaded the heated intraoperative chemotherapy (HIPEC) for abdominal malignancy in collaboration with surgical oncology and BWH-Dana-Farber Cancer Institute. In 2018, we launched the Dana-Farber Cancer Institute Gynecological HIPEC program for patients with ovarian cancer. All three programs, named 3Ps (pleural, peritoneal and pelvic) HIPEC, remain vibrant and highly successful in promoting wellness to patients at the Brigham and Women's Hospital in Boston. In Academia, I have been involved with graduate medical education of medical students, residents, fellows, physician assistants and health care providers since 2005. I have been directly responsible for surgical education in trauma, general surgery, thoracic surgery, lung transplantation, and leadership formation at Penn State University Medical College, Loyola University Medical Center, and Harvard Medical School. I have been an invited speaker at national and international forums in several aspects of medical education. I have had the privilege to mentor many national and international students and residents and made a tangible contribution to each and all of them. In the research arena, my focus has been on clinical protocols and in the development of new surgical approaches to complex surgical problems.
